Etiology, Pathophysiology, Diagnosis and Management of Kawasaki Disease

Abdulghani Alzamzami,Osama Almuqaytib,Ahmad Alsaadi,Ahmed Alasmari,Khalid Alsuwat,Ahmed Al Abdullah,Abdulaziz Alomair,Asalah Alomair,Noor Alawami,Anas Alamodi,Abdullah Alismail,Bandar Alenezi
DOI: https://doi.org/10.52533/johs.2024.40109
2024-01-01
Journal of Healthcare Sciences
Abstract:Kawasaki Disease (KD) has been a challenge in medicine ever since it was first described in 1967. This illness presents as a fever accompanied by a range of mucocutaneous symptoms making it crucial to have sharp diagnostic skills. It is characterized by inflammation of arteries throughout the body particularly affecting the cardiovascular system. Suspected triggers include agents, genetic factors and immune responses. KD pathophysiology is closely linked to dysregulation, especially involving inflammatory cytokines. Diagnosis relies on criteria such as fever for more than five days and specific symptoms. The primary pharmacological treatments involve immunoglobulin (IVIG) and aspirin to reduce inflammation and prevent complications in the arteries. In cases corticosteroids and immunomodulatory agents may be considered. Long term follow-up with collaboration among healthcare professionals is essential for monitoring any abnormalities in the arteries. Echocardiography plays a role in this process by providing insights into complications that may arise over time. Ongoing research aims to explore options as part of a comprehensive approach to KD management that emphasizes continuous research and an adaptable strategy for achieving the best possible outcomes.
What problem does this paper attempt to address?